Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-07-20 | 2023-07-20 |
| Drug Identification Number | 02245948 | 02245948 |
| Brand name | LEVOTHYROXINE SODIUM FOR INJECTION | LEVOTHYROXINE SODIUM FOR INJECTION |
| Common or Proper name | LEVOTHYROXINE SODIUM FOR INJECTION | LEVOTHYROXINE SODIUM FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM |
| Strength(s) | 500MCG | 500MCG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10mL | 10mL |
| ATC code | H03AA | H03AA |
| ATC description | THYROID PREPARATIONS | THYROID PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-03-31 | 2023-03-31 |
| Actual start date | 2023-03-31 | 2023-03-31 |
| Estimated end date | 2023-06-15 | 2023-06-15 |
| Actual end date | 2023-06-16 | 2023-06-16 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Levothyroxine Sodium Injection 100 mcg/mL SD Vial 5 mL is available for substitution. | Levothyroxine Sodium Injection 100 mcg/mL SD Vial 5 mL is available for substitution. |
| Health Canada comments |